Heterogeneity and endotypes in type 1 diabetes mellitus

Area of Science:

• Immunology
• Genetics
• Metabolic Science
• Endocrinology

Background:

• Type 1 diabetes mellitus (T1DM) treatment and prevention remain challenging, with significant individual variability in response to therapies.
• Current diabetes classifications do not adequately address the disease's complexity or guide personalized clinical management.
• Precision medicine necessitates identifying distinct disease endotypes for targeted interventions.

Purpose of the Study:

• To explore the heterogeneity within T1DM by identifying distinct endotypes.
• To analyze epidemiological, clinical, genetic, immunological, histological, and metabolic differences within T1DM.
• To assess the impact of emerging endotypes on T1DM prediction, prevention, and treatment strategies.

Main Methods:

• Comprehensive analysis of epidemiological data.
• Clinical phenotyping of T1DM patients.
• Genetic and immunological profiling.
• Histological examination of pancreatic tissues.
• Metabolic assessment and characterization.

Main Results:

• Significant heterogeneity observed across multiple dimensions of T1DM.
• Distinct differences in etiology and pathogenesis identified within T1DM.
• Emerging endotypes demonstrate potential for stratifying patients based on disease characteristics.

Conclusions:

• T1DM is a heterogeneous disease, not a single entity.
• Identification of T1DM endotypes is essential for advancing precision medicine in diabetes.
• Understanding endotypes will improve prediction, prevention, and treatment efficacy for T1DM.